VanEck Vectors Morningstar Durable Dividend ETF DURA 深 沪
等待开盘 08-16 09:30:00 美东时间
33.7167
0.000
0.00%
华盛通- 最 高0.00
- 今 开33.7167
- 成交量 568股
- 最 低 0.00
- 昨 收 33.7167
- 总市值 4551.75万
- 52周最高 34.1492
- 市盈率 静 --
- 换手率 0.04%
- 52周最低 28.8141
- 委 比 33.33%
- 总股本 135.00万
- 历史最高 34.1492
- 量 比 0.30
- 振 幅 0.00%
- 历史最低 14.258
- 每 手 1
- 风险率 0.92%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多HPQ Silicon Begins Production of Advanced Battery Cells
HPQ-Silicon Resources ( ($TSE:HPQ) ) has provided an update. HPQ Silicon Inc. h...
08-14 19:43
EyePoint Pharma Enrolls And Randomizes Over 400 Patients In Phase 3 LUGANO Pivotal Trial Of DURAVYU For Wet AMD Treatment
– Over 400 patients enrolled and randomized over a seven-month period, driven by strong physician and patient interest –– LUCIA pivotal Phase 3 trial continues rapid enrollment pace with 60% of patients
05-27 19:02
BioMarin Reports Fourth Quarter and Full Year 2024 Results; Sets Full Year 2025 Guidance
Strong Execution and Operational Transformation in 2024 Delivered Record Full Year Results and Provides Momentum for Double-Digit Revenue and Profitability Growth in 2025 4Q 2024 Total Reven...
02-20 05:05
宝理塑料基于全新工业后回收系统推出40%玻璃纤维增强再生DURAFIDE PPS
近日，工程塑料领域的全球领导者宝理塑料株式会社宣布，根据其机械回收业务计划，公司将于2025年12月前推出一款40%玻璃纤维增强等级的DURAFIDE® rG...
02-11 11:37
Argenx Secures Japanese Approval for VYVDURA in CIDP Treatment
Argenx Se ( ($ARGX) ) has provided an update. Argenx SE announced that Japan’s ...
2024-12-27 19:28
Rocky Mountain Chocolate Factory Announces Board Changes
DURANGO, Colo., Dec. 02, 2024 (GLOBE NEWSWIRE) -- Rocky Mountain Chocolate Fact...
2024-12-03 05:00
Argenx Advances Clinical Development of Efgartigimod SC in Idiopathic Inflammatory Myopathies
Phase 2 data establish proof-of-concept of efgartigimod SC in myositis Enrollm...
2024-11-20 14:00
Reported Earlier, EyePoint Pharmaceuticals Prices Upsized $140M Public Offering Of 12,727,273 Common Shares At $11/Share
EyePoint intends to use the net proceeds that it will receive from the offering to advance clinical development of DURAVYU™ for wet age related macular degeneration (wet AMD) and diabetic macular edema (DME), as
2024-10-30 14:54
